Anyone with a history of 'significant' allergies to food or medicines should avoid the current Pfizer COVID-19 vaccine, the UK regulator said, after 2 people had reactions
- Two recipients of Pfizer and BioNTech's
COVID-19 vaccinehad adverse reactions Tuesday, the UK's National Health Service said Wednesday morning.
- Both people, who are recovering, had a history of "significant" allergic reactions.
- As a result, the UK drug regulator has warned people with a history of significant allergic reactions to food, medicine, or vaccines to avoid the Pfizer vaccine in its current state.
- "As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination," Stephen Powis, the national medical director for the NHS in England, said.
The UK's drug regulator has warned that people with a history of "significant" allergic reactions should not receive Pfizer and BioNTech's
The UK began rolling out the vaccine Tuesday, following approval by its Medicines and Healthcare products Regulatory Agency on December 2. Two
"As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday," Powis said, using an abbreviation for the UK drug regulator.
This includes people with a history of reactions to medicines, food, and vaccines, the MHRA said.
"Any person with a history of a significant allergic reaction to a vaccine, medicine, or food (such as previous history of anaphylactoid reaction or those who have been advised to carry an adrenaline autoinjector) should not receive the Pfizer/BioNtech vaccine," according to the advice issued by the MHRA.
The people who suffered the reactions were NHS staff members who received the shot Tuesday and developed reaction symptoms shortly afterward.
Both people's history with allergic reactions was significant enough that they carried adrenaline auto injectors with them, The Independent reported.
"Both are recovering well," Powis added.
Authorities have not yet said which element of the vaccine the staff members were allergic to.
All regions involved with the vaccination program have been alerted, NHS England said, and starting Wednesday all patients receiving the vaccine will be asked beforehand whether they have a history of allergic reactions.
Vaccination should be carried out only in facilities where resuscitation measures are available, the regulator added.
A Pfizer representative told Sky its vaccine was "well tolerated" during trials with more than 44,000 participants, with "no serious safety concerns."
"We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the COVID-19 BNT162b2 vaccine," the representative said.
"As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation."
The US could approve the vaccine as early as Thursday.
- I just got laid off from my dream job at Tesla without warning. I feel like my life got uprooted so a billionaire could save some money.
- Four-days work week, full and final settlement within 2 days of exit — new changes at workplaces to reflect from July 1
- Mark Zuckerberg told Meta staff he's upping performance goals to get rid of employees who 'shouldn't be here,' report says
- Antonia Wade, PwC's global CMO, tells Insider how B2B spending changes in tough economic times
- Ban on single-use plastic kicks in across India as the country recognises the choking impacts of plastic waste on the environment
- Bank FDs will draw down from mutual funds if interest rates go up to 7.5-8%, says report
- Best smartphones under ₹40,000 in India
- Are we worse off than we were in 2008? Foreign investors seem to think so